Condition
Metastatic Ovarian Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Metastatic Ovarian Carcinoma clinical trials that are recruiting, at sites in 4 countries (most in United States (4), Poland (1), South Korea (1)). By phase: Phase 1 (5), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Metastatic Ovarian Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Evaluating NKT3964 for Adults with Advanced Solid Tumors | Phase 1 | Little Rock, Arkansas and 20 other locations | Recruiting | Sep 19, 2024 |
| Evaluating OATD-02 for advanced solid tumors | Phase 1 | Bydgoszcz, Kuyavian-Pomeranian Voivodeship and 2 other locations | Recruiting | Mar 8, 2023 |
| CPI-613 combined with hydroxychloroquine and chemotherapy for advanced solid tumors | Phase 2 | Chicago, Illinois | Recruiting | Feb 17, 2023 |
| Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors | Phase 1 | Houston, Texas | Recruiting | Oct 25, 2021 |
| Combination of PIPAC and systemic chemotherapy for advanced ovarian cancer | Phase 1 | Lille and 5 other locations | Recruiting | Mar 23, 2021 |
| Using pressurized aerosol chemotherapy to treat advanced abdominal cancers | Phase 1 | Duarte, California and 2 other locations | Recruiting | Apr 1, 2020 |
All recruiting trials (6)
-
Evaluating NKT3964 for Adults with Advanced Solid Tumors
This study is testing a new drug called NKT3964 to see if it can safely help adults with advanced solid tumors, like ovarian or triple-negative breast cancer, after other treatments have failed.
-
Evaluating OATD-02 for advanced solid tumors
This study is testing a new oral medication called OATD-02 to see if it can help people with advanced solid tumors, like colorectal and ovarian cancer, by making their tumors respond better to treatment.
-
CPI-613 combined with hydroxychloroquine and chemotherapy for advanced solid tumors
This study is testing a new combination of treatments, including CPI-613 and hydroxychloroquine, to see if it can help people with advanced solid tumors that haven't improved with other chemotherapy.
-
Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors
This study is testing a new treatment that combines tumor treating fields with two different cancer drugs to see if it helps people with advanced solid tumors in the abdomen or chest.
-
Combination of PIPAC and systemic chemotherapy for advanced ovarian cancer
This study is testing a new way to give chemotherapy for women with advanced ovarian cancer who haven't responded well to previous treatments, by combining a special spray method with regular chemotherapy to see how safe it is and what the best dose is.
-
Using pressurized aerosol chemotherapy to treat advanced abdominal cancers
This study is testing a new way to deliver chemotherapy directly into the abdomen using a special aerosol spray to see if it helps people with advanced abdominal cancers feel better and have fewer side effects.
Related topics
Quick answers
How many Metastatic Ovarian Carcinoma clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (4 trials), Poland (1 trial), South Korea (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 5, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.